Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma

Stefan Hohaus, Manuela Giachelia, Giuseppina Massini, Barbara Vannata, Marianna Criscuolo, Maurizio Martini, Francesco D'Alo', Maria Teresa Voso, Luigi Maria Larocca, Giuseppe Leone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

29 Citazioni (Scopus)


We studied plasma levels of IL-10 and five single nucleotide polymorphisms in the interleukin-10 (IL-10) gene promoter in patients with Hodgkin lymphoma (HL) to address potential genotype-phenotype correlations. Patients with elevated IL-10 levels were more likely to have advanced stage disease and inferior event-free survival. Homozygous carriers of the variant alleles at position -592 (AA) and -1082 (GG) of the IL-10 promoter had higher IL-10 plasma levels, independent of male gender and advanced stage of disease which also determined increased IL-10 production. This analysis indicates that the genetic background can modulate plasma levels of IL-10, and ultimately prognosis in HL.
Lingua originaleEnglish
pagine (da-a)1352-1356
Numero di pagine5
RivistaLeukemia Research
Stato di pubblicazionePubblicato - 2009


  • Adult
  • DNA, Neoplasm
  • Epstein-Barr Virus Infections
  • Female
  • Gene Amplification
  • Genetic Variation
  • Herpesvirus 4, Human
  • Hodgkin Disease
  • Homozygote
  • Humans
  • Interleukin-10
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Promoter Regions, Genetic


Entra nei temi di ricerca di 'Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma'. Insieme formano una fingerprint unica.

Cita questo